Drug Overdose Response Investigation (DORI) Data Collections

ICR 201411-0920-013

OMB: 0920-1054

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supplementary Document
2014-11-25
Supporting Statement B
2015-03-06
Supporting Statement A
2015-03-06
IC Document Collections
ICR Details
0920-1054 201411-0920-013
Historical Active
HHS/CDC 14ARR
Drug Overdose Response Investigation (DORI) Data Collections
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 03/10/2015
Retrieve Notice of Action (NOA) 12/10/2014
For any Gen ICs with statistical methods, a Part B will be submitted for review along with the Gen IC and template.
  Inventory as of this Action Requested Previously Approved
03/31/2018 36 Months From Approved
8,100 0 0
4,050 0 0
0 0 0

State and local health authorities frequently call upon CDC's National Center for Injury Prevention and Control (NCIPC) to assist in their response to urgent public health problems resulting from drug use, misuse, abuse, and overdose. When called, NCIPC supports the states and local health authorities by conducting Drug Overdose Response Investigations (DORI), which entails a rapid and flexible epidemiological response. Urgent requests such as DORIs depend on the time and resources available, number of persons involved, and other circumstances unique to the urgent conditions at hand and usually involve the development of procedures, specific data collection instruments, and the collection of critical data. This request is for a new generic approval to conduct information collections during DORIs. A three-year clearance is requested to ensure: (1) rapid deployment data collection tools and (2) timely information collection of vital information. Of particular interest is response to increasing trends in, or changing characteristics of, overdose from prescription drugs (with a special interest in opioid analgesics such as oxycodone or methadone; benzodiazepines such as alprazolam) and/or illicit drugs (e.g., heroin). Specifically, this request covers investigative collections with the following aims: (1) To understand sudden increases in drug use and misuse associated with fatal and nonfatal overdoses; (2) to understand the drivers and risk factors associated with those trends; and (3) to identify the groups most affected. This will allow CDC to effectively advise states on recommended actions to control local epidemics. Thus, the ultimate goals of these collections are to minimize adverse health consequences, provide epidemiological data collection support to the states and, based on the findings from the investigation, appropriately assist with implementation of prevention and control measures.

US Code: 42 USC 241 Name of Law: Public Heath Service Act
  
None

Not associated with rulemaking

  79 FR 47640 08/14/2014
79 FR 70189 11/25/2014
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 8,100 0 0 8,100 0 0
Annual Time Burden (Hours) 4,050 0 0 4,050 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
NCIPC submission 0920-14ARR is a NEW Generic ICR.

$70,220
No
No
No
No
No
Uncollected
Jeffrey Zirger 404 639-7118 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/10/2014


© 2024 OMB.report | Privacy Policy